Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemochromatosis.

Pierre Brissot1, Antonello Pietrangelo2, Paul C Adams3

  • 1INSERM, Univ. Rennes, INRA, Institut NUMECAN (Nutrition Metabolisms and Cancer) UMR_A 1341, UMR_S 1241, F-35000 Rennes, France.

Nature Reviews. Disease Primers
|April 6, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the divide: GP narratives on lung cancer care in Tasmania.

Australian journal of primary health·2026
Same author

High performance deep-learning model for the diagnosis of auto-immune hepatitis based on histological whole slide images.

Virchows Archiv : an international journal of pathology·2026
Same author

Investigating synovial trace elements as diagnostic markers in acute septic arthritis: an exploratory study.

Clinical rheumatology·2026
Same author

Implementing good life with OsteoArthritis from Denmark (GLA:D®) in public outpatient settings in Tasmania, Australia.

Osteoarthritis and cartilage open·2026
Same author

Characterization of ferroportin disease and SLC40A1-related hemochromatosis - Results from the EASL non-HFE registry.

Journal of hepatology·2026
Same author

A Systematic Review and Narrative Synthesis of Factors Impacting Late Diagnosis of Chronic Hepatitis B and C.

Health science reports·2026

Hereditary hemochromatosis is a genetic disorder causing systemic iron overload due to reduced hepcidin. Diagnosis involves noninvasive methods, and treatment primarily uses phlebotomy.

Area of Science:

  • Genetics
  • Hematology
  • Endocrinology

Background:

  • Hereditary hemochromatosis involves systemic iron overload of genetic origin.
  • It stems from reduced hepcidin hormone concentration or impaired hepcidin-ferroportin binding.
  • Hepcidin is crucial for regulating ferroportin, the sole cellular iron exporter.

Purpose of the Study:

  • To define hereditary hemochromatosis, its genetic causes, and diagnostic approaches.
  • To outline current and potential future therapeutic strategies.
  • To elucidate the role of hepcidin and ferroportin in iron regulation.

Main Methods:

  • Review of genetic mutations in HFE, HAMP, HJV, TFR2, and SLC40A1.
  • Description of diagnostic methods including clinical examination, iron parameter assessment, imaging, and genetic testing.

Related Experiment Videos

  • Discussion of therapeutic interventions such as phlebotomy and iron chelation.

    • Main Results:

    • The most common form is linked to HFE gene mutations (C282Y).
    • Rarer forms involve mutations in HAMP, HJV, TFR2, or SLC40A1, affecting hepcidin-ferroportin interaction.
    • Iron overload leads to accumulation in hepatocytes, pancreatic cells, and cardiomyocytes.

    Conclusions:

    • Hereditary hemochromatosis is a genetically determined iron overload disorder.
    • Diagnosis relies on noninvasive clinical, biochemical, imaging, and genetic evaluations.
    • Phlebotomy remains the primary treatment, with hepcidin supplementation as a future possibility.